Indeed, our data indicate that Pim inhibitors can block the pro-migratory effects of NFATc factors in prostate cancer cells, suggesting that regulation of NFATc activity may be one of the mechanisms how Pim kinases promote cancer cell motility. Here, PIM1 is linked to Familial prostate cancer.